Dmitry S. Petelin , Polina S. Isaeva , Maya V. Ksenofontova , Olga Yu. Sorokina , Beatrice A. Volel
Abstract
Chronic pain is one of the main problems of modern clinical medicine. It is associated with its high prevalence, negative impact on the level of development and the life quality of patients, as well as difficulties in selecting effective drug therapy. According to various data, the population prevalence of chronic pain during life varies from 11% to 40%. Modern publications have proven the connection of various pain syndromes with unpredictable psychopathological conditions, including affective disorders, anxiety disorders, addiction to psychoactive substances, and personality disorders. Currently, a large number of methods that reduce the severity of chronic pain are available. Due to the emphasis of this article on the consequences associated with painful disorders, only methods used in psychiatric practice are discussed. This includes psychopharmacotherapy, psychotherapy and non-drug biological methods of therapy. In order to illustrate the main provisions presented in the review literature, the article offers a clinical observation.
Keywords: pain, chronic pain, therapy, clinical observation, mental disorders, comorbidity.
Keywords: pain, chronic pain, therapy, clinical observation, mental disorders, comorbidity.
About the Author
Dmitry S. Petelin 1 , Polina S. Isaeva 2 , Maya V. Ksenofontova 3 , Olga Yu. Sorokina 1 , Beatrice A. Volel 41 Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
2 Russian Medical Academy of Continuous Professional Education, Moscow, Russia
3 Moscow State University of Psychology and Education, Moscow, Russia
4 Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia; Mental Health Research Center, Moscow, Russia
References
1. Данилов А.Б. Биопсихосоциокультурная модель и хроническая боль. Современная терапия в психиатрии и неврологии. 2013;(1):30-6.
Danilov A.B. Biopsychosociocultural model and chronic pain. Modern therapy in psychiatry and neurology. 2013;(1):30-6 (in Russian).
2. Аверченкова А.А., Парфенов В.А. Клинико-психологический и нейрофизиологический профиль пациентов с хронической люмбалгией. Российский журнал боли. 2015;(1):59.
Averchenkova A.A., Parfenov V.A. Clinical, psychological and neurophysiological profile of patients with chronic lumbalgia. The Russian Journal of Pain. 2015;(1):59 (in Russian).
3. Волель Б.А, Петелин Д.С, Рожков Д.О. Хроническая боль в спине и психические расстройства. Неврология, нейропсихиатрия, психосоматика. 2019;(11):17-24.
Volel B.A., Petelin D.S., Rozhkov D.O. Chronic back pain and mental disorders. Neurology, neuropsychiatry, psychosomatics. 2019;(11):17-24 (in Russian).
4. Dahlhamer J, Lukas J, Zelaya C et al. Prevalence of chronic pain and high-impact chronic pain among adults. Morbidity and mortality daily report 2018;67(36):1001-6.
5. Fayaz A, Croft P, Langford R et al. Prevalence of chronic pain in the UK: A systematic review and meta-analysis of population studies. BMJ Open 2016;(6):6.
6. Elliott AM, Smith BH, Hannaford PC et al. The course of chronic pain in the community: results of a 4-year follow-up study. Pain 2002;99(1);299-307.
7. Breiwik H, Collett B, Ventafridda V et al. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. European Journal of Pain 2006;10(4):287.
8. Mills SE, Nicolson KP, Smith BH. Chronic pain: a review of its epidemiology and associated factors in population-based studies. Br J Anaesth 2019;123(2):273-83.
9. Naik AK Tandan SK, Dudhgaonkar SP et al. Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-L-cysteine in rats. Eur J Pain 2006;10(7):573.
10. Cusi K, Isaacs S, Barb D et al. American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings. Endocr Pract 2022;28(5):528-62.
11. Hitt HC, McMillen RC, Thornton-Neaves T et al. Comorbidity of obesity and pain in a general population: results from the Southern Pain Prevalence Study. J Pain 2007;8(5):430.
12. Du J, Liu Y, Yan W. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. Eur Urol 2020;78
(2):64.
13. Paras ML, Murad MH, Chen LP et al. Sexual abuse and lifetime diagnosis of somatic disorders: a systematic review and meta-analysis. JAMA 2009;302(5):550.
14. Aguglia A, Salvi V, Maina G, Rossetto I et al. Fibromyalgia syndrome and depressive symptoms: Comorbidity and clinical correlates. J of Affective Disorders 2011;128(3):262-6.
15. Giannakopoulos N.N., Keller L., Rammelsberg P., Schmitter M. et al.. Anxiety and depression in patients with chronic temporomandibular pain and in controls. Journal of Dentistry 2010;38(5):369-76.
16. Dersh J, Gatchel RJ, Mayer T et al. Prevalence of psychiatric disorders in patients with chronic disabling occupational spinal disorders. Spine 2006;31(10):1156-62.
17. Sasaki T, Minagawa M, Yamamoto T, Ichihashi H. A case of the Rett syndrome with acute encephalopathy induced during calcium hopantenate treatment. Brain Dev 1991;13(1):52-5.
18. Arnold LM, Hudson JI, Keck PE et al. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 2006;67(8):1219-25.
19. Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 2004;5(3):143-9.
20. Raphael KG, Janal MN, Nayak S et al. Psychiatric comorbidities in a community sample of women with fibromyalgia. Pain 2006;124(1-2):117-25.
21. Burris JL, Cyders MA, de Leeuw R et al. Posttraumatic stress disorder symptoms and chronic orofacial pain: an empirical examination of the mutual maintenance model. J Orofac Pain 2009;23(3):243-52.
22. Häuser W, Jung E, Erbslöh-Möller B et al. Validation of the Fibromyalgia Survey Questionnaire within a cross-sectional survey. PLoS One 2012;7(5):e37504.
23. Van Oudenhove L, Törnblom H, Störsrud S et al. Depression and Somatization Are Associated With Increased Postprandial Symptoms in Patients With Irritable Bowel Syndrome. Gastroenterology. 2016;150(4):866-74.
24. McWilliams LA, Goodwin RD, Cox BJ. Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain 2004;111(1-2):77-83.
25. Clemens JQ, Brown SO, Calhoun EA. Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome: a case/control study. J Urol 2008;180(4):1378-82.
26. Murphy LB, Sacks JJ, Brady TJ et al. Anxiety and depression among US adults with arthritis: prevalence and correlates. Arthritis Care Res (Hoboken) 2012;64(7):968-76.
27. Demyttenaere K, Bruffaerts R, Lee S et al. Mental disorders among persons with chronic back or neck pain: results from the World Mental Health Surveys. Pain 2007;129(3):332-42.
28. Martell BA, O’Connor PG, Kerns RD et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 2007;146(2):116-27.
29. Vowles KE, McEntee ML, Julnes PS et al. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain 2015;156(4):569-76.
30. Boscarino JA, Rukstalis M, Hoffman SN, Han JJ. Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction 2010;105(10):1776-82.
31. Boscarino JA, Rukstalis MR, Hoffman SN, Han JJ et al. Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteria. J Addict Dis 2011;30(3):185-94.
32. Raphael KG, Janal MN, Nayak S et al. Psychiatric comorbidities in a community sample of women with fibromyalgia. Pain 2006;124(1-2):117-25.
33. Demyttenaere K, Bruffaerts R, Lee S et al. Mental disorders among persons with chronic back or neck pain: results from the World Mental Health Surveys. Pain 2007;129(3):332-42.
34. Arnold LM, Hudson JI, Keck PE et al. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 2006;67(8):1219-25.
35. Alonso-Morán E, Orueta JF, Fraile Esteban JI et al. The prevalence of diabetes-related complications and multimorbidity in the population with type 2 diabetes mellitus in the Basque Country. BMC Public Health 2014;14:1059.
36. Saunders K, Merikangas K, Low NC et al. Impact of comorbidity on headache-related disability. Neurology 2008;70(7):538-47.
37. Reme SE, Tangen T, Moe T, Eriksen HR. Prevalence of psychiatric disorders in sick listed chronic low back pain patients. Eur J Pain 2011;15(10):1075-80.
38. Zhao Y, Liu J, Zhao Y, Thethi T et al. Predictors of duloxetine versus other treatments among veterans with diabetic peripheral neuropathic pain: a retrospective study. Pain Pract 2012;12(5):366-73.
39. Evers AWM, Kraaimaat FW, van Riel PLCM, Bijlsma JWJ. Cognitive, behavioral and physiological reactivity to pain as a predictor of long-term pain in rheumatoid arthritis patients. Pain 2001;93(2):139-46.
40. Cvijetic S, Bobic J, Grazio S et al. Quality of Life, Personality and Use of Pain Medication in Patients with Chronic Back Pain. Applied Research Quality Life 2014;(9):401–11.
41. Ramírez-Maestre C, López Martínez AE, Zarazaga RE. Personality characteristics as differential variables of the pain experience. J Behav Med 2004;27(2):147-65.
42. Kadimpati S, Zale EL, Hooten MW et al. Associations between Neuroticism and Depression in Relation to Catastrophizing and Pain-Related Anxiety in Chronic Pain Patients. PLoS One 2015;10(4):e0126351.
43. Uguz F, Ciçek E, Salli A et al. Axis I and Axis II psychiatric disorders in patients with fibromyalgia. Gen Hosp Psychiatry 2010;32(1):105-7.
44. Weisberg JN. Personality and personality disorders in chronic pain. Curr Rev Pain 2000;4(1):60-70.
45. Finnerup NB, Attal N, Haroutounian S et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015;14(2):162-73.
46. Bonilla-Jaime H, Sánchez-Salcedo JA, Estevez-Cabrera MM et al. Depression and Pain: Use of Antidepressants. Curr Neuropharmacol 2022;20(2):384-402.
47. Iancu I, Lowengrub K, Dembinsky Y et al. Pathological gambling: an update on neuropathophysiology and pharmacotherapy. CNS Drugs 2008;22(2):123-38.
48. Ferreira GE, Abdel-Shaheed C, Underwood M et al. Efficacy, safety, and tolerability of antidepressants for pain in adults: overview of systematic reviews. BMJ 2023;380:e072415.
49. Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet 2021;397(10289):2082-97.
50. Finnerup NB, Attal N, Haroutounian S et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015;14(2):162-73.
51. Williams AC, Eccleston C, Morley S. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev 2012;11(11):CD007407.
52. Hughes LS, Clark J, Colclough JA et al. Acceptance and Commitment Therapy (ACT) for Chronic Pain: A Systematic Review and Meta-Analyses. Clin J Pain 2017;33(6):552-68.
53. Hilton L, Hempel S, Ewing BA et al. Mindfulness Meditation for Chronic Pain: Systematic Review and Meta-analysis. Ann Behav Med 2017;51(2):199-213.
54. Hamid P, Malik BH, Hussain ML. Noninvasive Transcranial Magnetic Stimulation (TMS) in Chronic Refractory Pain: A Systematic Review. Cureus 2019;11(10):e6019.
55. Young NA, Sharma M, Deogaonkar M. Transcranial magnetic stimulation for chronic pain. Neurosurg Clin N Am 2014;25(4):819-32.
56. Lloyd DM, Wittkopf PG, Arendsen LJ, Jones AKP. Is Transcranial Direct Current Stimulation (tDCS) Effective for the Treatment of Pain in Fibromyalgia? A Systematic Review and Meta-Analysis. J Pain 2020;21(11-12):1085-100.
57. Lefaucheur JP, Antal A, Ayache SS et al. Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS). Clin Neurophysiol 2017;128(1):56-92.
58. Bittar RG, Kar-Purkayastha I, Owen SL et al. Deep brain stimulation for pain relief: a meta-analysis. J Clin Neurosci 2005;12(5):515-9.
59. Hamani C, Schwalb JM, Rezai AR et al. Deep brain stimulation for chronic neuropathic pain: long-term outcome and the incidence of insertional effect. Pain 2006;125(1-2):188-96.
60. Green AL, Owen SL, Davies P, Moir L. Deep brain stimulation for neuropathic cephalalgia. Cephalalgia 2006;26(5):561-7.
For citation:Petelin D.S., Isaeva P.S., Ksenofontova M.V., Sorkina O.Yu., Volel B.A. Chronic pain comorbid with mental disorders: literature review and clinical case. Clinical review for general practice. 2024; 5 (8): 62–70 (In Russ.). DOI: 10.47407/kr2024.5.8.00461
All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
